Partnering

Strategic Partnerships - Advancing the Future of Diagnostics Together

At MagQu, we're focused on pioneering immunomagnetic reduction technology and in vitro diagnostic solutions. We firmly believe that close collaboration with a wide range of partners, including CLIA Laboratories, other Clinical Laboratories, and diverse business development partners, is essential to translate groundbreaking science into meaningful clinical impact. If you share our passion for scientific advancement and our vision for the future, we invite you to explore partnership opportunities with us and help build a new era in diagnostics.

Clinical Lab Partnerships

  • Integrate our immunomagnetic reduction technology into your existing testing.

  • Receive expert support for implementation, validation, and performance optimization.

  • Benefit from comprehensive regulatory compliance assistance.

  • Access ongoing technical training and support.

Pharmaceutical R&D Collaboration

  • Collaborate on companion diagnostics development.

  • Utilize our high-sensitivity detection for biomarker validation.

  • Leverage our expertise for clinical trial testing support.

  • Partner on customized assay development for specific research needs.

  • Explore our technology for novel biomarker discovery.

Research & Technology Alliances

  • Engage in joint research programs to advance diagnostics.

  • Access our platform technology for research purposes.

  • Collaborate on funding applications.

  • Participate in knowledge exchange and joint publications.

  • Explore opportunities for student and postdoctoral programs.